NCT07604064
- Conditions
- Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, +2 more
- Locations
-
- Research Site Tokyo and Other Japanese Cities, Japan
Clinical trial condition
Relapsed or Refractory IDH1 Mutation-Positive Acute Myeloid Leukemia
Explore clinical trials studying Relapsed or Refractory IDH1 Mutation-Positive Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study